Gyre Therapeutics
GYRE----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Gyre Therapeutics(GYRE) predict that the Revenue is 22.52 M (+2.09%), Miss estimate;the EBIT is -9.355 M (--%), Beat estimate;the EPS is -0.1 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.02B2.09%
0.03B43.29%
-0.01B41.20%
EBITExceed expectations
-0.01B--
-0.01B--
+0.00B--%
EPSMiss expectations
-0.1--
-0.0733--
-0.0267--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf